Cargando…
TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
Summary: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), whi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443685/ https://www.ncbi.nlm.nih.gov/pubmed/25638808 http://dx.doi.org/10.1093/bioinformatics/btv067 |
_version_ | 1782373038602321920 |
---|---|
author | He, Liye Wennerberg, Krister Aittokallio, Tero Tang, Jing |
author_facet | He, Liye Wennerberg, Krister Aittokallio, Tero Tang, Jing |
author_sort | He, Liye |
collection | PubMed |
description | Summary: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), which predicts the effects of drug combinations based on their binary drug-target interactions and single-drug sensitivity profiles in a given cancer sample. Here, we report the R implementation of the algorithm (TIMMA-R), which is much faster than the original MATLAB code. The major extensions include modeling of multiclass drug-target profiles and network visualization. We also show that the TIMMA-R predictions are robust to the intrinsic noise in the experimental data, thus making it a promising high-throughput tool to prioritize drug combinations in various cancer types for follow-up experimentation or clinical applications. Availability and implementation: TIMMA-R source code is freely available at http://cran.r-project.org/web/packages/timma/. Contact: jing.tang@helsinki.fi Supplementary information: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-4443685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44436852015-06-05 TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples He, Liye Wennerberg, Krister Aittokallio, Tero Tang, Jing Bioinformatics Applications Notes Summary: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), which predicts the effects of drug combinations based on their binary drug-target interactions and single-drug sensitivity profiles in a given cancer sample. Here, we report the R implementation of the algorithm (TIMMA-R), which is much faster than the original MATLAB code. The major extensions include modeling of multiclass drug-target profiles and network visualization. We also show that the TIMMA-R predictions are robust to the intrinsic noise in the experimental data, thus making it a promising high-throughput tool to prioritize drug combinations in various cancer types for follow-up experimentation or clinical applications. Availability and implementation: TIMMA-R source code is freely available at http://cran.r-project.org/web/packages/timma/. Contact: jing.tang@helsinki.fi Supplementary information: Supplementary data are available at Bioinformatics online. Oxford University Press 2015-06-01 2015-01-31 /pmc/articles/PMC4443685/ /pubmed/25638808 http://dx.doi.org/10.1093/bioinformatics/btv067 Text en © The Author 2015. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Applications Notes He, Liye Wennerberg, Krister Aittokallio, Tero Tang, Jing TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
title | TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
title_full | TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
title_fullStr | TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
title_full_unstemmed | TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
title_short | TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
title_sort | timma-r: an r package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples |
topic | Applications Notes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443685/ https://www.ncbi.nlm.nih.gov/pubmed/25638808 http://dx.doi.org/10.1093/bioinformatics/btv067 |
work_keys_str_mv | AT heliye timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples AT wennerbergkrister timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples AT aittokalliotero timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples AT tangjing timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples |